10 completed, 2 unknown, 1 recruiting, 1 terminated. 4 Phase 2, 3 Phase 1, 3 Phase 4, 2 Phase 3, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 1 | 3 | Completed 2, Unknown 1 |
| Phase 4 | 3 | Completed 3 |
| Phase 3 | 2 | Terminated 1, Unknown 1 |
| Not applicable | 1 | Recruiting 1 |
Follow Flupenthixol: new trials by email Literature Review of Flupenthixol trials Research Report on Flupenthixol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Cognitive Behavioral Therapy Through a Mobile App on Patients With Refractory Functional Dyspepsia cognitive behavioural therapy mobile application, Flupentixol and Melitracen Tablets - Functional Dyspepsia, Self-help Mobile Cognitive Behavioral Therapy | Not applicable | Recruiting | Air Force Military Medical University, China | 88 | 2024-11-01 | 2025-07-01 |
| Adjunctive Use of Fute (Flupentixol) in Multi-acting Receptor-targeted Antipsychotics Treated Schizophrenia Patients Flupentixol, Multi-acting receptor-targeted antipsychotics (MARTAs) - Schizophrenia; Psychosis, Metabolic Syndrome | Phase 4 | Completed | Taichung Veterans General Hospital | 30 | 2019-12-19 | 2021-05-24 |
| Comparative Study of the Pharmacokinetics and Bioequivalence of Two Flupentixol Formulations 0.5 mg Flupentixol film-coated tablet (test treatment), 1 mg Flupentixol film-coated tablet (test treatment), 5 mg Flupentixol film-coated tablet (test treatment) - Bioequivalence Study in Healthy Subjects | Phase 1 | Completed | H. Lundbeck A/S | 84 | 2016-01-01 | 2016-07-26 |
| Pharmacovigilance in Gerontopsychiatric Patients Phenobarbital, Phenytoin, Carbamazepine - Dementia, Depression | Phase 3 | Terminated | Hannover Medical School | 407 | 2015-01-01 | 2018-02-28 |
| Bioequivalence Study in Healthy Men and Women to Compare Two Pharmaceutical Formulations of Flupentixol/Melitracen (Deanxit®) Flupentixol/melitracen film-coated tablet, Flupentixol/melitracen coated tablet (Deanxit®) - Healthy Men and Women | Phase 1 | Completed | H. Lundbeck A/S | 30 | 2014-06-01 | 2014-09-04 |
| Compliance With Antidepressant Medication in Treatment of Functional Dyspepsia Omeprazole, Flupentixol-Melitracen(psychological and GI) + Omeprazole, Flupentixol-Melitracen(psychological) + Omeprazole - Dyspepsia, Compliance | Phase 4 | Completed | RenJi Hospital | 262 | 2013-05-01 | 2015-02-23 |
| Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis Discontinuation antipsychotic treatment, Antipsychotic treatment - Psychosis Nos/Other | Phase 3 | Unknown | Fundación Pública Andaluza Progreso y Salud | 104 | 2012-11-01 | 2014-12-05 |
| Antipsychotics and Risk of Hyperglycemic Emergencies Olanzapine, Risperidone, atypical antipsychotics (other) - Psychotic Disorders, Schizophrenia | Completed | Canadian Network for Observational Drug Effect Studies, CNODES | 725489 | 2012-04-01 | 2015-10-21 | |
| Clinical Effectiveness of Newer Antipsychotics in Comparison With Conventional Antipsychotics in Schizophrenia Olanzapine, Flupentixol, Quetiapine - Schizophrenia | Phase 4 | Completed | University of Bremen | 149 | 2010-02-01 | 2015-06-22 |
| Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9 Flupenthixol - Cocaine-Related Disorders, Substance-Related Disorders | Phase 2 | Completed | National Institute on Drug Abuse (NIDA) | 60 | 1997-03-01 | 2017-01-12 |
| Cocaine Abuse and ADHD - 10 Flupenthixol - Cocaine-Related Disorders | Phase 2 | Completed | National Institute on Drug Abuse (NIDA) | 16 | 1996-11-01 | 2017-01-12 |
| Flupenthixol Treatment in Schizophrenic Cocaine Abusers - 1 Flupenthixol - Cocaine-Related Disorders | Phase 2 | Completed | National Institute on Drug Abuse (NIDA) | 1994-08-01 | 2017-01-12 | |
| Flupenthixol Decanoate in Methamphetamine Smoking - 1 Flupenthixol - Substance-Related Disorders | Phase 2 | Completed | National Institute on Drug Abuse (NIDA) | 58 | 1994-02-01 | 2017-01-12 |
| Infusion Laboratory: Protocol 5 (Flupenthixol) - 14 Flupenthixol - Cocaine-Related Disorders | Phase 1 | Unknown | National Institute on Drug Abuse (NIDA) | 2017-01-11 |
Cocaine-Related Disorders (4) · Schizophrenia (4) · Depression (2) · Psychotic Disorders (2) · Substance-Related Disorders (2) · Anxiety Disorders (1) · Bipolar Disorder (1) · Central Nervous System Diseases (1) · Dementia (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1) · Drug-Related Side Effects and Adverse Reactions (1) · Dyspepsia (1) · Metabolic Syndrome (1) · Patient Compliance (1)
National Institute on Drug Abuse (NIDA) (5) · H. Lundbeck A/S (2) · Air Force Military Medical University, China (1) · Canadian Network for Observational Drug Effect Studies, CNODES (1) · Fundación Pública Andaluza Progreso y Salud (1) · Hannover Medical School (1) · RenJi Hospital (1) · Taichung Veterans General Hospital (1) · University of Bremen (1)
United States (5) · China (2) · Germany (2) · Canada (1) · Russia (1) · Spain (1) · Taiwan (1) · United Kingdom (1)
Herbert Kleber, M.D. (3) · Chia-Jui Tsai, M.D. (1) · Frank Gawin, M.D. (1) · Helge Frieling, Prof., MD (1) · Lorraine Lipscombe, MD, MSc (1) · Miguel Ruiz Veguilla, MD, PhD (1) · Shengliang Chen (1) · Walter Ling, M.D. (1)
PMID 24581419, PMID 25914475, PMID 27016729, PMID 27265548, PMID 30981585, PMID 38958149
2009 (1), 2014 (1)